Aspira Pathlab & Diagnostics reports standalone net profit of Rs 0.99 crore in the September 2024 quarter

Net profit of Aspira Pathlab & Diagnostics reported to Rs 0.99 crore in the quarter ended September 2024 as against net loss of Rs 0.71 crore during the previous quarter ended September 2023. Sales rose 86.14% to Rs 6.18 crore in the quarter ended September 2024 as against Rs 3.32 crore during the previous quarter ended September 2023.

Particulars	Quarter Ended
	Sep. 2024	Sep. 2023	% Var.
Sales	6.18	3.32	86
OPM %	21.84	-10.84	-
PBDT	1.35	-0.32	LP
PBT	0.99	-0.71	LP
NP	0.99	-0.71	LP